Recruiting

Biomarker Identification

Sponsor:

Sync-Think, Inc.

Code:

NCT04504890

Conditions

ADHD - Combined Type

ADHD

ADHD Predominantly Inattentive Type

ADHD, Predominantly Hyperactive - Impulsive

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

EYE-SYNC

Study Details

Brief summary:

This study intends to establish a relationship between oculovestibular eye tracking measures, measures of ADHD, and medication prescribed for ADHD.

Conditions

ADHD - Combined Type

ADHD

ADHD Predominantly Inattentive Type

ADHD, Predominantly Hyperactive - Impulsive

Study ID

NCT04504890

Start date

Jul 16, 2020

Status verified date

Oct, 2020

Completion date

Oct 5, 2021

Anticipated

Primary completion date

Aug 5, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Men and women ages 6-70 seeking evaluation and treatment for ADHD.

Exclusion Criteria:

  • Clinical diagnosis of a neurological condition including the following: stroke, multiple sclerosis, epilepsy, brain tumor/cancer, dyslexia, nystagmus and/or other major neurological condition.

  • Clinical diagnosis of any of the following eye-sight abnormalities: uncorrected amblyopia, uncorrected myopia, uncorrected presbyopia, uncorrected farsightedness or uncorrected Astigmatism.
  • Psychiatric history with any of the following:
  • LIFETIME: Clinical diagnosis of a psychotic disorder; bipolar disorder
  • LAST YEAR: Clinical diagnosis of major depressive disorder; PTSD; clinical diagnosis of substance abuse disorder; major anxiety disorder

  • Use of a psychotropic medication
  • Impairment of cranial nerves II-VI
  • Participants who receive a 'Poor' or 'Fair' eye tracking quality result on either their baseline or follow-up evaluations will be excluded from analysis. Subjects may not repeat participation

Study Design

Enrollment

240 participants

Anticipated

Interventions and Outcome Measures

Arms

Adults - Diagnosis

Adults seeking treatment for an attention-related disorder

Adults - Prescribed

Adults who have been diagnosed with ADHD and prescribed medication treatment for the disorder

Children - Diagnosis

Children seeking treatment for an attention-related disorder

Children - Prescribed

Children who have been diagnosed with ADHD and prescribed medication treatment for the disorder

Interventions

EYE-SYNC

Nystagmograph used to measure eye movement

Primary outcome measure

  • Eye Tracking and ADHD measure correlation [ Time Frame: through study completion, an average of 1 year ]
  • Eye Tracking ADHD Diagnostic ROC [ Time Frame: through study completion, an average of 1 year ]
  • MANCOVA Eye Tracking in ADHD Treatment Population [ Time Frame: through study completion, an average of 1 year ]

Central Contacts and Locations

Central contacts

Benjamin Cheyette, M.D.,Ph.D.

650.278.1814cheyetbr@sutterhealth.org

Locations

Palo Alto Medical Foundation - San Carlos Center

Recruiting

San Carlos, California, United States, 94070

Contacts

Benjamin Cheyette, M.D., Ph.D.

650-278-1814cheyetbr@sutterhealth.org

Sarah Cheyette, M.D.

CheyetS@sutterhealth.org

Principal Investigator:

Benjamin Cheyette, M.D., Ph.D.

More Information

Sponsor

Sync-Think, Inc.

Last update posted

Oct 23, 2020

Last verified

Oct, 2020

Keywords

  • ADHD
  • EYE-SYNC
  • eye tracking
  • oculomotor
  • vestibular

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Sync-Think, Inc. on 2020-10-23.